5 'Strong Buy' Biotech Stocks to Buy for 2020 ... the gains and losses in even the best biotech stocks hinge less on earnings results, and more on a few key indicators such as trial-data … It hopes to soon begin late-stage testing in the U.S. and Mexico, as well. Cumulative Growth of a $10,000 Investment in Stock Advisor, 3 Top Biotech Stocks to Buy Right Now @themotleyfool #stocks $NVAX $VRTX $EXEL $BMY $RHHBY $RDY $CRSP, These 2 Companies May Be the Next to Enter the U.S. Vertex's theme song could be MC Hammer's "U Can't Touch This." 15 Largest Biotech Companies In The World. Gilead stock has a lucrative annual dividend yield of 4%. For some stocks, though, what the overall market does won't matter very much. Exelixis' flagship product Cabometyx is currently approved by the U.S. Food and Drug Administration (FDA) as a second-line treatment for renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). 7 Exciting Biotech Stocks to Buy Now Don't let the train leave the station without you. Regeneron Pharmaceuticals (NASDAQ:REGN) has been soaring thanks to its blockbuster drugs Eylea and Dupixent. Overall, Gilead's revenue and earnings per share (EPS) grew annually by 10% and 16% from 2019, to $24.3 billion and $7.09. Lives in Québec City, Canada. That makes ABBV one of the best biotech stocks to buy for investors seeking out income in 2021 and beyond. The 7 Best Biotech Stocks to Buy Today Biotech stocks are having a moment as the world hopes for a cure to the pandemic. Bernstein analyst Ronny Gal projects that the biotech will rake in $3.8 billion in sales from its COVID vaccine next year. Best Penny Stocks To Buy Now? So, selecting the right investments is just as important as making the investment itself. Vertex and CRISPR Therapeutics could have a cure potentially on the way for rare blood disorders sickle cell disease and beta-thalassemia with CTX001. No other drugmaker has a CF candidate beyond phase 2 clinical testing. Despite all its potential, Johnson & Johnson is only trading at 5.3 times revenue and 22.8 times free cash flow. Will the stock market continue to soar in 2021? This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. Cancer Genetics Inc. (NASDAQ: CGIX) Bio-Path Holdings … 1. Disclosure: None. One of the interesting things for investors to … Novavax is currently evaluating the vaccine in a late-stage study in the U.K. Stock Advisor launched in February of 2002. 3 Biotech Stocks To Watch In January Sunesis Pharmaceuticals Inc.. Shares of Sunesis Pharma have been on the rise since the middle of last quarter. Best Biotech Stocks To Buy Right Now? Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Market data powered by FactSet and Web Financial Group. Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer. Vertex developed and markets all of them. Its tremendous profits continue to add to its huge cash stockpile of over $6 billion. ... but upcoming clinical trial results could be the real reason to buy shares now. While that may not seem like a significant increase, its stock is already trading at rock-bottom valuations. This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. J&J expects to deliver 100 million doses to the U.S. by the end of June and plans to manufacture 1 billion doses by the end of the year. I'm also optimistic about Vertex's pipeline prospects. 10 Best Biotech Stocks To Invest In. The 8 Best SPACs To Buy For January 2021 – Don’t Miss These SPACS; The 8 Best Stocks Under $2 To Buy … This is a solid biotech stock you do not want to miss. What Really Mattered With Novavax's Q4 Update, Copyright, Trademark and Patent Information. Novavax also teamed up with other companies to sell NVX-CoV2373 in India, Japan, South Korea, and other low- and middle-income countries. In clinical trials, the candidate demonstrated 66% efficacy at preventing COVID-19 infections and 85% efficacy in stopping severe cases of the diseases. It's surprising to me that Exelixis (NASDAQ:EXEL) isn't bigger than its current market cap of a little over $6 billion. Market data powered by FactSet and Web Financial Group. NASDAQ:EXEL) has developed four drugs that … Vertex Pharmaceuticals. PerkinElmer Inc. … Thanks to the success of Cabometyx, Exelixis has steadily built up its cash position, which totaled $1.5 billion as of Sept. 30, 2020. In addition, it reduced the risk of death among patients who are severely ill with the disease by 22%. 10 Best Small-Cap Biotech Stocks Under $10 in 2021 is originally … These biotech stocks are set to soar. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. We’re motley! His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Gilead also projects it can grow its sales and EPS to $25.1 billion and $7.45 for 2021. Vaccine Market, These 2 Elements in Novavax's Earnings Report Could Mean Billions for the Biotech. As an icing on the cake, its multi-billion-dollar biotech acquisitions are about to add impressive growth to its bottom-line. Novavax's COVID Vaccine Trial: Are There Any Yellow Flags So Far? Speaking of vaccines, the company filed for emergency regulatory authorization of its own single-dose coronavirus prophylactic. In particular, biotech stocks can be practically bulletproof. The 8 Best Penny Stocks To Buy Now – Don’t Miss These; These Are The 10 Best Drone Stocks To Buy Right Now! Here are three top biotech stocks to buy right now. 15 Best Technology Stocks To Buy Now. Last year, it brought in $82.6 billion in revenue and reached $8.93 EPS, compared to sales of $82.1 billion and EPS of $7.5 in 2019, respectively. Unlike other sectors, one major driver behind biotech firms' momentum is their dedication to research and development. Here are the top biotech stocks … Its HIV drug, Biktarvy, is the number one most prescribed regimen for the disease in the U.S. About 1 in 2 patients with HIV receive the treatment. With two potential blockbuster vaccines on the way and a market cap around $8 billion, Novavax could skyrocket in 2021. However, I believe that Novavax just might be the biggest winner of the three biotech stocks over the next few years. 06, 2020 5:57 PM ET ACAD, AGN, ... Top-rated biotech stocks to buy. Best Value Biotech Stocks . The so-so performance is largely due to the COVID-19 pandemic, which caused a decline in demand for non-essential medical procedures and equipment. Zhiyuan Sun is a statistician with a knack for analyzing clinical trials and company financials. Johnson & Johnson (NYSE:JNJ) is a world leader in consumer health, pharmaceuticals, and medical devices, with 28 of its products generating at least $1 billion in annual sales. 10 Best Water Stocks and ETFs to Buy in 2021. Alexion Pharmaceuticals (ALXN) is also among top biotech stocks to watch. Axsome Therapeutics. Regeneron Pharmaceuticals Regeneron Pharmaceuticals ( … Best Biotech Stocks To Buy [Or Avoid] Now. 3 Best Biotech Stocks to Buy Right Now Biotech is on every investor's mind as we move closer and closer to a successful vaccine for the coronavirus. Trading at 6.2 times revenue and 36.4 times free cash flow, its stock seems rather more expensive than its peers on this list. We’re motley! Biotech stocks have been on fire for much of the past 12 months, enjoying record levels of investor enthusiasm. Disclosure: None. Next year, however, the company expects to increase its sales and EPS sharply, to upwards of $90 billion and $9.50 as the pandemic subsides with the launch of coronavirus vaccines. ET The drug generated an additional $2.5 billion in sales year over year in 2020. RCC is the most common form of kidney cancer, while HCC is the most common form of liver cancer. Top Biotech Stocks To Buy [Or Sell] This Week. I genuinely think that Vertex Pharmaceuticals ( NASDAQ:VRTX) is the best biotech stock on the market. Gilead Sciences Gilead Sciences ( NASDAQ:GILD) has had everyone talking after announcing superb 2020 results,... 2. That's over twice the amount the S&P 500 had in the bag for investors during the same period. Just last month, Regeneron secured a $2.625 billion contract with the Department of Defense (DoD) to provide 1.25 million doses of its coronavirus antibody cocktail, REGN-COV2. Best Biotech Stocks To Buy [Or Sell] Now. This year, it expects to sell an additional $2 billion to $3 billion worth of the antiviral. You can buy Gilead shares for just 3.7 times revenue, which is far cheaper than the industry average of eight times revenue. Their fortunes usually hinge on pipeline developments that have nothing to do with what's going on in the rest of the world. Special: Forget Bitcoin - Buy These 3 Cryptos in 2021; Best Biotech Stock #1: Vertex Pharmaceuticals (VRTX) One of the top biotech stocks in the industry, Vertex is focused on … I look for solid sales growth over the next few years as the company secures additional reimbursement deals in key European markets. Approximately 67% of the free cash flow Gilead generates goes into shareholders' pockets, with $5 billion in dividends paid and $1.583 billion in stock buybacks in 2020. That said, here is a list of top biotech stocks for you to consider buying. Fool since April 2020. The biotech could generate close to $950 million in revenue this year. Best biotech stocks 1. The Best Biotech Stocks To Buy Now. Vertex is on track to generate sales of at least $6 billion this year, more than 40% higher than the $4.2 billion reported for 2019. Top Biotech Stocks to Buy for 2021 Here are the biotech stocks to buy that we think will see magnified growth over the coming year. However, it has more than enough growth to make up for its current premium. Are These The Best Biotech Penny Stocks To Buy Right Now? Here are three contenders for … REGN-COV2 prevented 57% of COVID-19 related medical visits in the overall population after dosage in clinical testing. Exelixis is also working with Roche to evaluate a combination of Cabometyx with Tecentriq in late-stage studies targeting several types of cancer, including RCC and non-small cell lung cancer. 5 Biotech Stocks To Know Published: Nov. 29, 2020 at 3:14 p.m. The … 1. The company is rolling in dough. It also has 30 therapeutics in development and plans to file regulatory approval for 14 new molecules and indications by 2023. The iShares NASDAQ Biotechnology ETF (NASDAQ:IBB), a benchmark for sector performance, offered a return of 42% over the past year as of Feb. 9. So far, the company has lined up supply deals with the U.S., U.K., Australia, Canada, and New Zealand totaling nearly 287 million doses. Investors are clearly undervaluing its opportunity to make tens of billions in additional this year contingent on its vaccine candidate receiving regulatory clearance. However, the biotech hopes to receive FDA approval early next year for a combo of Cabometyx and Bristol Myers Squibb's immunotherapy Opdivo as a first-line RCC therapy. Axsome ( NASDAQ:AXSM) has a lead candidate, AXS-05, that targets depression and Alzheimer’s... 2. There are currently four approved drugs in the U.S. and Europe that treat the underlying cause of CF. The nanoparticle-based flu vaccine handily outperformed market leader FluZone Quadrivalent in a late-stage study completed earlier this year. Right now, Regeneron generates about $2 billion in free cash flow, has over $4.7 billion in cash net of debt, and plans to buy back $1.5 billion worth of its stock this year. Returns as of 03/06/2021. ... (Buy) now sees shares hitting $126, Arlinda Lee raised her price … Real Money writer Bret Jensen reveals his top picks. This is a, Cumulative Growth of a $10,000 Investment in Stock Advisor, 3 Best Biotech Stocks to Buy Now @themotleyfool #stocks $GILD $JNJ $REGN $IBB, Gilead Sciences and Galapagos Shutter Their Pulmonary Fibrosis Program, Here's the Key to Gilead Sciences' Q4 Earnings Beat, Gilead Sciences (GILD) Q4 2020 Earnings Call Transcript, Copyright, Trademark and Patent Information. The center of attention for Novavax is its experimental COVID-19 vaccine NVX-CoV2373. 3 Top Biotech Stocks to Buy Right Now. Biotech stocks have been on fire for much of the past 12 months, enjoying record levels of investor enthusiasm. Gilead Sciences (NASDAQ:GILD) has had everyone talking after announcing superb 2020 results, especially in its antiviral pipeline. Last year, it brought $20 billion in free cash flow, invested $12.2 billion in research and development, and paid $10.5 billion to shareholders via dividends. A new Stifel research report includes the firm's biotech stock picks for 2021. As an icing on the cake, its multi-billion-dollar, Despite all its potential, Johnson & Johnson is only trading at 5.3 times revenue and 22.8 times free cash flow. A significant factor behind the increases is its coronavirus treatment drug Veklury (also known as remdesivir), which brought $2.8 billion in sales since it came on the market in May 2020. The biotech did have a setback this year for one candidate targeting rare genetic disease alpha-1 antitrypsin deficiency (AATD). Press Release Are These The Best Penny Stocks To Buy Now? 3 Top Biotech Stocks to Buy Now Here are the best biotech stocks for investors looking for market-beating performance. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. In addition, Novavax hopes to win FDA approval for flu vaccine NanoFlu. 4 Reporting Earnings This Week. Gilead stock has a lucrative annual dividend yield of 4%. The gene-editing therapy is currently in early-stage testing with promising initial results. … More sales growth should be on the way in 2021 and beyond. Or will another crash be right around the corner? Shareholders will be partaking in the company's success. Best Biotech Stocks to Buy Right Now. 5 Booming Biotech Stocks to Buy These five biotech stocks have already gone on heaters of 30% or more in 2020, and all of them still have plenty of upside to spare. Last year, it grew its revenue and EPS by approximately 30% year after year to $8.5 billion and $31.47 respectively. With that in mind, here is a list of top biotech stocks that are trending this month. Returns as of 03/06/2021. 10 Best Technology Stocks That Pay Dividends. Mar. The stock has an annual yield of 2.42%. had in the bag for investors during the same period. Novavax (NASDAQ:NVAX) is listed last on the list because it doesn't yet have an approved product on the market and is therefore a riskier pick than Vertex or Exelixis. Keep in mind; the catalyst is not part of Johnson & Johnson's 2021 guidance. This could open up a much larger market opportunity. Companies in the industry typically reinvest more than 20% of their revenue in developing new treatment and therapies. By Mark Reeth , Contributor Oct. 21, 2020 The. G1 Therapeutics (GTHX, $16.12) is among the very best biotech stocks to buy right now, based on analysts' estimates. Approximately 67% of the free cash flow Gilead generates goes into shareholders' pockets, with $5 billion in dividends paid and $1.583 billion in stock buybacks in 2020. Earlier this year, Alexion inked a deal … There are plenty of opportunities in the biotechnology space, but, as with any sector, there are also plenty of risky plays. Stock Advisor launched in February of 2002. As we turn the page on 2020, there are quite a lot of penny stocks in focus. Many biotechs have products on the market that are so critical for patients that sales will keep growing even if the economy tanks. Vertex Pharmaceuticals Inc. ( NASDAQ: VRTX) Bio-Techne Corporation ( NASDAQ: TECH) PerkinElmer Inc. ( ... Vertex Pharmaceuticals Inc. Bio-Techne Corporation. The company makes Soliris, a blockbuster rare-disease treatment. Biotech Stocks Under $1. But which stocks are good picks? I think Exelixis' strategy of building its pipeline is a good one that could pay off nicely over the long run. Investing in healthcare and cannabis is his passion, as well as looking out for new, actionable stock investment ideas in these sectors. 12 Best Genomic Stocks To Buy Now is … It should do much to help the company's already massive profitable bottom line. Investors are clearly undervaluing its opportunity to make tens of billions in additional this year contingent on its vaccine candidate receiving regulatory clearance. I genuinely think that Vertex Pharmaceuticals (NASDAQ:VRTX) is the best biotech stock on the market. Over the past 12 months, shares of Regeneron are already up more than 29%. It also prevented 100% of symptomatic infections if administered early. The reality is that no other company can touch its dominance in the cystic fibrosis (CF) market. Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer. GTHX is advancing promising therapies for people who are living with … Today, let us look at three top biotech stocks and how they could add wealth to your portfolio in the coming months. In fact,... Venus Concept Inc.. Another one of the biotech penny stocks gaining ground recently is Venus Concept. Exelixis. The great news for Vertex is that its latest blockbuster CF drug, Trikafta/Kaftrio, has just begun to pick up momentum in Europe. However, Vertex has another AATD candidate in phase 2 testing and a promising program targeting genetic kidney diseases. The company is using its newfound wealth to expand its pipeline, recently licensing programs from Iconic Therapeutics and Aurigene, a subsidiary of Dr. Reddy's Laboratories. Price ($) Market Cap ($M) 12-Month Trailing P/E Ratio: Catalyst Pharmaceuticals Inc. ( CPRX) 3.43: 355.5: 5.1: Innoviva Inc. 10.62: 1,077: 5.4: Voyager … No one knows what will happen for sure.